Skip to main content

CCTG Connection



Published:
Category: Publications

The San Antonio Breast Cancer Symposium (December 7-10, 2021) is currently underway at the Gonzalez Convention Center  in San Antonio, Texas and online.The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

Where and when to see CCTG studies at SABCS 2021:

Read More

Published:
Category: Publications

ASH 2021 is and important gathering of scientist interested  in malignant and non-malignant hematology. This year the event will be held at the Georgia World Congress Center in Atlanta, Georgia or virtually from December 11-14, 2021,  where they present the newest advances in hematology.

Here is a list of the CCTG studies at ASH next week.

Read More

Published:
Category: Trials
The HN10 study, "A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma has closed to accrual after reaching its accrual target.
Read More



Published:
Category: Group updates
The CommNETs Annual Research Workshop will be held virtually via Zoom November 30th to December 2nd (Canada) and December 1st to 3rd (Australia and New Zealand).

The CommNETs Annual Research Workshop will be held virtually via Zoom November 30th to December 2nd (Canada) and December 1st to 3rd (Australia and New Zealand). 

Read More

Published:
Category: News
Cancer continues to be a leading cause of death in Canada and around the world. The Canadian Cancer Trials Group (CCTG), based at Queen’s University in Kingston, Ontario, plays a critical role in the fight against cancer by designing and administering clinical trials in cancer therapy, supportive care and prevention across Canada. Read More

Published:
Category: Publications

The CCTG BR34: A randomized phase II trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic non-small cell lung cancer study results were recently published in the Journal of Thoracic Oncology.

Read More



Published:
Category: Group updates
Information for sites participating in trials that are sending samples to the CCTG Tissue Bank during the upcoming holiday season. Read More

Published:
Category: Group updates

Reporting to the Information Technology (IT) Program Manager, the Web Application Developer is responsible for the entire project/software lifecycle which consists of the following components: application architecture, input/output design, system specifications, process mapping, user requirements, layouts, user interface, database design/programming, test plans and training.

Find out more

Read More